Anda belum login :: 04 Jun 2025 15:16 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Comparison of vaginal misoprostol and dinoprostone for cervical ripening before diagnostic hysteroscopy in nulliparous women
Oleh:
Inal, Hasan Ali
;
Inal, Zeynep Hafiza Ozturk
;
Tonguc, Esra
;
Var, Turgut
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 103 no. 05 (May 2015)
,
page 1326–1331.
Topik:
Cervical ripening
;
dinoprostone
;
hysteroscopy
;
misoprostol
Ketersediaan
Perpustakaan FK
Nomor Panggil:
F02.K
Non-tandon:
tidak ada
Tandon:
1
Lihat Detail Induk
Isi artikel
Objective To compare the effectiveness of vaginal misoprostol and dinoprostone for cervical ripening before diagnostic hysteroscopy in nulliparous women. Design Placebo-controlled, double blind, randomized trial. Setting Teaching and research hospital. Patient(s) Ninety women of reproductive age eligible for diagnostic hysteroscopy. Intervention(s) Randomly assignment to receive 400 µg of misoprostol (n = 30) or 10 mg of dinoprostone (n = 30) vaginally before diagnostic hysteroscopy, with a control group (n = 30) not receiving any cervical priming agent. Main Outcome Measure(s) Primary outcome: the number of women requiring cervical dilatation; secondary outcomes: cervical width before surgery, duration of dilatation time, ease of dilatation, complications during surgical procedure, and side effects of the drugs. Result(s) In the placebo group, 23 patients required cervical dilatation compared with 17 in the misoprostol group and 9 in the dinoprostone group. The mean (± standard deviation) cervical widths for the placebo, misoprostol, and dinoprostone groups were 4.23 ± 0.43 mm, 5.43 ± 0.5 mm, and 5.83 ± 0.64 mm, respectively. These widths were statistically significantly different. The duration of dilatation was also statistically significantly longer in the control group. Conclusion(s) Vaginally administered dinoprostone before diagnostic hysteroscopy is more effective than misoprostol for inducing cervical priming. Further studies are required to elucidate the most efficient option with the least side effects for cervical ripening.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0 second(s)